Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S1W-07241 · Session 1

What criteria were used to determine which multiple sclerosis sufferers were suitable to receive beta interferon treatment, what criteria w…

Answered Asked by Des McNulty Lab Lodged 25 May 2000

The question

To ask the Scottish Executive what criteria were used to determine which multiple sclerosis sufferers were suitable to receive beta interferon treatment, what criteria were used to determine which patients received treatment using the drug, and what proportion of those deemed suitable actually received the treatment.

The answer

Answered by Susan Deacon on 1 Aug 2000 · 68 days after it was lodged, 54 days after it was due

There is no information held centrally on the number of patients with multiple sclerosis who may be eligible for beta interferon treatment. A patient's eligibility for this treatment depends on the clinical judgement of the specialists concerned, taking account of advice from health board drug and therapeutic committees.

In the Official Report

No contribution in the Official Report cites S1W-07241 by reference.